IR-Med Inc.
IRME · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,899 | -$4,909 | -$4,734 | -$3,716 |
| Dep. & Amort. | $21 | $17 | $10 | $5 |
| Deferred Tax | $0 | -$55 | $0 | $0 |
| Stock-Based Comp. | $485 | $1,682 | $1,330 | $1,339 |
| Change in WC | $5 | -$25 | $47 | -$121 |
| Other Non-Cash | $2 | $58 | -$28 | $11 |
| Operating Cash Flow | -$1,386 | -$3,232 | -$3,375 | -$2,482 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$2 | -$50 | -$31 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$9 | -$30 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$9 | -$30 |
| Investing Cash Flow | $0 | -$2 | -$59 | -$61 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5 | $0 | $0 | $0 |
| Stock Issued | $755 | $1,000 | $3,625 | $3,491 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1,000 | $0 | $0 |
| Financing Cash Flow | $750 | $1,000 | $3,625 | $3,491 |
| Forex Effect | -$2 | -$1 | -$4 | $1 |
| Net Chg. in Cash | -$638 | -$2,235 | $187 | $949 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $767 | $3,002 | $2,815 | $1,866 |
| End Cash | $129 | $767 | $3,002 | $2,815 |
| Free Cash Flow | -$1,386 | -$3,234 | -$3,425 | -$2,513 |